ANDREW WILLSON: Open Payments
NPI 1952770976 · BAY CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,777 in 147 payments from 26 companies in 2025. Trend: 2023 $2,244 · 2024 $2,378 · 2025 $2,777
Food & beverage: $2,777
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $353 |
| Vanda Pharmaceuticals Inc. | 14 | $323 |
| AstraZeneca Pharmaceuticals LP | 9 | $288 |
| Lilly USA, LLC | 16 | $258 |
| Novo Nordisk Inc | 12 | $221 |
| PFIZER INC. | 14 | $217 |
| GlaxoSmithKline, LLC. | 21 | $150 |
| Novartis Pharmaceuticals Corporation | 5 | $113 |
| Dexcom, Inc. | 2 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $88 |
Products named: FANAPT, QULIPTA, MOUNJARO, BREZTRI, TRELEGY ELLIPTA, REXULTI, Wegovy, LEQVIO.
Industry payments across MI — which companies pay providers there.
